<!doctype html>
<html lang="zh-CN">
<head>
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta charset="utf-8">
  <title>Safety</title>
  <link rel="stylesheet" href="/assets/css/styles.css">
</head>
<body>
  <button class="sidebar-toggle" aria-label="切换导航" aria-expanded="false">☰</button>
  <aside class="sidebar">
<a class="home" href="/"><img src="/assets/images/menu.webp" alt="主页"></a>
<!--SIDEBAR-START-->
<!-- 本文件由 inject-sidebar.js 自动生成 -->
<nav class="site-nav">
  <ul>
    <li><a href="/" class="home-link">Home</a></li>
    <li><span>Project</span>
  <ul>
<li><a href="/pages/1Project/1background.html">Background</a></li>
<li><a href="/pages/1Project/2description.html">Description</a></li>
<li><a href="/pages/1Project/3engineering.html">Engineering</a></li>
<li><a href="/pages/1Project/4contribution.html">Contribution</a></li>
<li><a href="/pages/1Project/5implementation.html">Implementation</a></li>
<li><a href="/pages/1Project/6project-future.html">Future Directions</a></li>  </ul>
</li>
<li><span>Dry Lab</span>
  <ul>
<li><a href="/pages/2Dry Lab/1design.html">Design</a></li>
<li><a href="/pages/2Dry Lab/2model.html">Model</a></li>  </ul>
</li>
<li><span>Wet Lab</span>
  <ul>
<li><a href="/pages/3Wet Lab/1wetlab-overview.html">Wet Lab Overview</a></li>
<li><a href="/pages/3Wet Lab/2gene-cleavage.html">Gene Cleavage Module</a></li>
<li><a href="/pages/3Wet Lab/3assembly.html">Assembly Module</a></li>
<li><a href="/pages/3Wet Lab/4validation.html">Functional Validation</a></li>
<li><a href="/pages/3Wet Lab/5wetlab-future.html">Future Directions</a></li>
<li><a href="/pages/3Wet Lab/6parts.html">Parts</a></li>  </ul>
</li>
<li><span>Human Practice</span>
  <ul>
<li><a href="/pages/4Human Practice/1human-practices.html">Human Practices</a></li>
<li><a href="/pages/4Human Practice/2entrepreneurship.html">Entrepreneurship</a></li>
<li><a href="/pages/4Human Practice/3collaborations.html">Collaboration</a></li>
<li><a href="/pages/4Human Practice/4safety.html">Safety</a></li>  </ul>
</li>
<li><span>Team</span>
  <ul>
<li><a href="/pages/5Team/1roster.html">Team Roster</a></li>
<li><a href="/pages/5Team/3awards.html">Awards</a></li>  </ul>
</li>

  </ul>
</nav>
<!--SIDEBAR-END-->
<a class="back-to-top" href="#" title="回到顶部"><img src="/assets/images/uptotop.webp" alt="回到顶部"></a>
</aside>

  <main class="content">
<div class="pagecontainer"><div class="title2"><span>Safety</span></div></div>

    <div class="pagecontent" id="auto-page-content">
<aside id="toc" class="toc"></aside>
<h2>Overview</h2><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Our project designs a <strong>DNA origami container carrying CRISPR-Cas9</strong>to specifically target the<strong><em>mecA</em></strong>gene responsible for methicillin resistance in Staphylococcus aureus (MRSA). We test feasibility <strong>only in safe laboratory <em>E. coli </em>models</strong> to explore whether such a strategy could reduce antibiotic-resistance phenotypes in the future.</p><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">What we do: Load sgRNA/Cas9 into DNA origami, evaluate in-vitro mecA cleavage, and use safe cellular surrogates (e.g., lacZ) for any in-cell tests.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Boundaries: No clinical isolates, no human/animal experiments, no release beyond containment. All work occurs in authorized BSL-1 labs and inside biosafety cabinets (BSC).</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">AMR risk mitigation: Dual layer genetic design to avoid HGT + strict operational containment.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Governance: iGEM Safety Form registered; IBC approval under Zhejiang University-University of Edinburgh Joint Institute (ZJE) teaching center rules.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">More compliance details: See Safety Form (submitted and passed initial review; includes lab photos, training &amp; facility info, and materials lists).</li></ul><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">1. Our Project &amp; Scope</h2><h3 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Standard laboratory strains used:</h3><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">E. coli ATCC 25922 — used for membrane-permeabilization assays</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">E. coli MG1655 — used for blue-white selection</li></ul><h3 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">AMR template strictly in vitro:</h3><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">The mecA gene was PCR-amplified from a purchased plasmid and used only as an in-vitro DNA template for cleavage validation.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">We do not express mecA in cells. For cellular-level validation, we use a safe reporter gene (lacZ) as the replacement target.</li></ul><h3 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Not included:</h3><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">No human/animal experiments</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">No clinical isolates</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">No Risk Group 3/4 pathogens</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">No unverified environmental or commercial sources</li></ul><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><em>More details:</em> Safety Form <a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" id="OLE_LINK21"></a><a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" id="OLE_LINK22"></a>3, 12, 17.</p><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">2. Governance &amp; Approvals</h2><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">iGEM compliance: We follow iGEM Prohibited Activities, White List, AMR Policy, and Release Beyond Containment guidelines. Because some of our planned work involves materials not covered by the White List, we submitted a Check-In Form to the iGEM Safety and Security Committee and received approval before starting.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Institutional review: We applied to use the ZJE Biomedical Teaching Center seminar lab (D501) under the open-use policy. The project is supervised by a PI, and IBC approval was obtained. Per institutional requirements, there are regular IBC inspections and PI supervision. Every student involved in wet-lab work signed a safety commitment form. Any change to the experimental plan is re-submitted for record and approval.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Training &amp; records:</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">All team members completed laboratory safety training and passed the Biomed-X Laboratory Safety Exam, which covered PPE usage, waste management, biosafety levels, equipment operation, and emergency response.</li></ul><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-0.webp"/></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure.</em></strong><em> Example page from the Biomed-X Laboratory Safety Exam, which all team members completed as part of mandatory safety training.</em></p><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Work was performed on open benches in a BSL-1 laboratory, which is appropriate for the organisms and parts we used.</li></ul><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-2.webp"/></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure.</em></strong><em> Sterile filtration of TAE/Mg²⁺ buffer performed at a clean bench, illustrating proper aseptic technique in a BSL-1 laboratory.</em></p><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">SDS are available for all reagents.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Daily experiment records are maintained.</li></ul><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><em>More details</em>: Safety Form 2, 24-27.</p><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">3. Intrinsic Biosafety by Design</h2><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">Our system layers <strong>genetic</strong>, <strong>payload</strong>, and <strong>material-level</strong> safeguards so function only occurs under narrowly defined, lab-controlled conditions, minimizing risks of HGT, unintended activation, and persistence outside containment.</p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" id="OLE_LINK25"></a><a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" id="OLE_LINK26"></a><strong>3.1 Genetic-level Safeguards (chassis &amp; vectors)</strong></p><h3 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">De-mobilization (no conjugation):</h3><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Plasmid backbones lack transfer determinants (e.g., oriT/tra/mob), preventing conjugation.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Constructs encode no integrases/transposases; no genomic integration functions.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Only involve plasmids in experiments in vitro; no risk of conjugation or genomic integration during the experimental process.</li></ul><h3 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Restricted host range (narrow replication):</h3><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Replicons are limited to laboratory E. coli; replication is not maintained in unrelated environmental or pathogenic strains.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Preference for non-broad-host-range origins further restricts maintenance.</li></ul><h3 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Single-use scope (no clinical amplification):</h3><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">All cloning/validation confined to BSL-1 E. coli.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">No propagation in clinical isolates or environmental samples.</li></ul><h3 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Sequence-level targeting hygiene:</h3><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">In cells we never target AMR genes; we use safe reporters (e.g., lacZ).</li></ul><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">3.2 Payload-level Safeguards (DNA origami CRISPR)</h2><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">3.2.1 Locked-then-unlock origami container:</h2><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Protection before entry: sgRNA/Cas9 are physically shielded inside the origami, reducing extracellular exposure and proteolysis.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Intracellular unlocking (dual-key): Gate 1SH cleaves disulfides; Gate 2: RNase H cuts engineered RNA-DNA hybrids to release sgRNA/Cas9 only after Gate 1.</li></ul><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">3.2.2 Aptamer targeting &amp; local enrichment:</h2><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Origami displays DNA aptamers recognizing bacterial surface motifs, enriching payload at the correct cells.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">NPN uptake assay: aptamer-origami-G4/hemin (DO<sup>A</sup><sub>PAM</sub>GH) shows higher fluorescence than non-aptamer controls (DO<sub>PAM</sub>GH) — local permeability enhancement.</li></ul><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" alt="NPN uptake assay results" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-3.webp"/></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure.</em></strong><em> NPN uptake assay comparing</em> <em>DO<sub>PAM</sub>GH and DO<sup>A</sup><sub>PAM</sub>GH. Aptamer decoration significantly increases RFU values, indicating enhanced membrane permeability.</em></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" alt="NPN uptake factor analysis" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-4.webp"/></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure.</em></strong><em> NPN uptake factor analysis showing DO<sup>A</sup><sub>PAM</sub>GH has higher uptake efficiency than DO<sub>PAM</sub>GH, confirming aptamer-mediated enrichment.</em></p><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Confocal microscopy: DO<sup>A</sup><sub>PAM</sub>GH yields significantly stronger fluorescence around E. coli than DO<sub>PAM</sub>GH controls — validating targeting effect.</li></ul><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">3.2.3 Membrane permeabilization via G4/hemin DNAzyme (self-limiting):</h2><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Origami-tethered G4/hemin (DO<sub>PAM</sub>GH) amplifies peroxidase-like activity, aiding transient permeabilization.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">ABTS assay: DO<sub>PAM</sub>GH shows higher absorbance at 415nm than free G4/hemin.</li></ul><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" alt="ABTS assay results" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-5.webp"/></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure.</em></strong><em> ABTS assay showing that</em><a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" id="OLE_LINK3"></a><em> DO<sub>PAM</sub>GH has significantly higher peroxidase-like activity than free G4/hemin or hemin alone, confirming catalytic amplification.</em></p><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">NPN uptake: DO<sub>PAM</sub>GH &gt; buffer; trends with EDTA positive control indicate designed outer-membrane disruption.</li></ul><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" alt="NPN uptake membrane permeability assay" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-6.webp"/></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure.</em></strong><em> NPN uptake assay (RFU) comparing buffer, cells, EDTA, and DO<sub>PAM</sub>GH. DO<sub>PAM</sub>GH significantly increases membrane permeability, consistent with the EDTA positive control.</em></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-7.webp"/></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure.</em></strong><em> NPN uptake factor analysis under the same conditions, further confirming that DO<sub>PAM</sub>GH enhances outer-membrane permeability compared with controls.</em></p><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Self-limitation: Requires hemin + H₂O₂ away from assay microenvironments, activity decays rapidly.</li></ul><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">3.2.4 Internalization as a hard gate:</h2><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Confocal imaging confirms intracellular signal with DO<sup>A</sup><sub>PAM</sub>GH; DO<sub>PAM</sub>GH controls are markedly lower.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">No internalization → no GSH trigger → no RNase H release → no CRISPR cleavage.</li></ul><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">3.2.5 Cleavage validation without AMR spread risk:</h2><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">In vitro only for mecA: mecA is PCR-amplified from a purchased plasmid and used solely as an in-vitro DNA template; never expressed in cells.</li></ul><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-8.webp"/></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure.</em></strong><em> In-vitro cleavage of PCR-amplified mecA fragment by sgRNA/Cas9, indicating the mecA gene was successfully cleaved.</em></p><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">In-cell surrogate: functional cutting was demonstrated using lacZ in E. coli MG1655, visualized via a blue-white selection. Successful Cas9 cleavage converted blue colonies to white, confirming intracellular function without involving AMR genes.</li></ul><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-9.webp"/></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure.</em></strong><em> Cleavage of lacZ reporter fragment in E. coli MG1655, used as a safe surrogate for in-cell validation.</em></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-10.webp"/></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure.</em></strong><em> Blue/White selection result. A. Numerous blue colonies were observed in the control group. B. Both blue and white colonies were observed in the experiment group treated with the origami platform.</em></p><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Assay pairing: membrane-permeabilization tests in E. coli ATCC 25922; reporter cutting in E. coli MG1655.</li></ul><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">3.3 Material-level Self-Limiting Features</h2><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Nuclease &amp; temperature sensitivity: DNA origami degrades under DNase and during prolonged 37°C incubation — natural fail-safe limiting persistence.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Cofactor dependency: G4/hemin activity strictly requires hemin/H₂O₂; without both, permeabilization does not proceed.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Post-release decay: Packaging protects Cas9 pre-entry, but after release Cas9 is subject to intracellular proteolysis, limiting lifetime.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Non-living carrier: DNA origami is non-replicating — no growth/colonization outside controlled experiments.</li></ul><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">4. Operational Controls</h2><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Laboratory level: all work was conducted in authorized BSL-1 facilities using open-bench practices suitable for Risk Group 1 organisms. No BSC was required, since we did not handle pathogens, clinical isolates, or Risk Group 2+ materials.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">PPE: lab coats, gloves, goggles; no food/drinks or unrelated items.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Waste disposal: all cultures and DNA materials autoclaved or chemically inactivated and disposed of as biomedical waste.</li></ul><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-11.webp"/></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure.</em></strong><em> Disposal of used syringe needles into a sharps container, demonstrating safe handling of sharp laboratory waste.</em></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-12.webp"/></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure.</em></strong><em> Autoclave used for sterilization of biological materials.</em></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-13.webp"/></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure.</em></strong><em> Sterilization of liquid laboratory waste prior to disposal, ensuring all effluents are inactivated.<img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-14.webp"/></em></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure.</em></strong><em> Segregation of ordinary trash and biological waste. Biological waste is collected in yellow medical-grade bags and handed over to licensed waste disposal companies.</em></p><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Inventory &amp; procurement management:</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">All strains, plasmids, and reagents were procured via the official Zhejiang University ordering system, ensuring traceability and institutional oversight.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Procurement logs confirm that mecA was obtained only as a commercial plasmid (for PCR template use only), and that all bacterial strains used (e.g., E. coli MG1655, ATCC 25922) are laboratory-safe strains.</li></ul><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><img style="max-width: 100%; height: auto; display: block; margin: 0 auto; overflow: hidden;" src="/static/_downloaded/static.igem.wiki/teams/5913/safety/safety-15.webp"/></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong><em>Figure</em></strong><em>. Record from the institutional procurement system, showing traceable purchase of laboratory-safe E. coli strains and commercial plasmids.</em></p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><em>More details</em>: Safety Form 2, 25-27.</p><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">5. AMR Risk: Response to Reviewer</h2><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><strong>Reviewer concern:</strong> Ensure <em>mecA</em> is not horizontally transferred.</p><h3 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">Our measures:</h3><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">1.	No <em>mecA</em> expression in clinical or pathogenic strains (indeed, <strong>never in cells</strong>).</p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">2.	<strong>Non-mobilizable plasmids</strong> lacking conjugation elements.</p><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;">3.	Workflow containment: all experiments were performed under <strong>BSL-1</strong> containment using open-bench practices; all waste was sterilized (autoclave/chemical inactivation), and no live material left the lab.</p><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">6. Chemicals &amp; Cyberbiosecurity</h2><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Chemicals: handled under SDS-based training (e.g., ethanol, Ni-NTA); fire protection and spill-prevention procedures in place.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Cyberbiosecurity: DNA/protein sequences stored on secured institutional servers with access control; no uncontrolled online sharing of engineered sequences.</li></ul><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">7. AI Tools Risk</h2><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">AI tools used for structure prediction and sequence assessment (e.g., AlphaFold/Rosetta as applicable).</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">No generative AI used to design novel risky sequences; all outputs undergo manual review by dry-lab and PI.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">No unverified sequences synthesized; only safe reporters or trusted-supplier fragments used.</li></ul><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><em>More details</em>: Safety Form 14.</p><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">8. Future Use &amp; No-Release Policy</h2><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Competition stage: laboratory in-vitro validation only; no in vivo or environmental release.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Hypothetical future: any animal/clinical step would require ethics review and compliance with applicable drug-regulatory pathways; this page is research documentation, not medical advice.</li></ul><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" id="OLE_LINK29"></a><a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" id="OLE_LINK30"></a><em>More details</em>: Safety Form 16-17, 23.</p><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">9. People &amp; Contacts</h2><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Team &amp; Responsibility: Principal Investigator (PI), Laboratory Safety Officer (BSO/EHS), and Team Safety Lead — all information is consistent with our Safety Form submission.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">External support and reporting pathway:</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">If a new risk is identified, the team will first conduct internal self-assessment,</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">then report to the PI and lab safety officer,</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">and finally escalate to the Institutional Biosafety Committee (IBC) for review if necessary.</li></ul><p style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; box-sizing: border-box; overflow: hidden;"><a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" id="OLE_LINK27"></a><a style="word-wrap: break-word; overflow-wrap: break-word; max-width: 100%; display: inline-block;" id="OLE_LINK28"></a><em>More details</em>: Safety Form 21.</p><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">10. Ethics &amp; Human Practices</h2><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">No human or animal samples were used in our experimental work.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Any future clinical applications would require ethics committee approval, informed consent, and strict data anonymization.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">For Human Practices activities (surveys, interviews):</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Participation is voluntary; participants may withdraw at any time.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">No personally identifiable information (PII) (e.g., name, phone, address, email) is collected.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">All responses are anonymized, used only for academic purposes, and stored in encrypted environments.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Data will be deleted at the end of the iGEM season (Dec 2025) or permanently anonymized if used for long-term display.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Participants have the right to access, modify, or withdraw any of their contributed data.</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">All practices follow GDPR standards and iGEM privacy policies.</li></ul><h2 style="color: #ffffff !important; text-shadow: 0 0 30px rgba(96, 165, 250, 0.8), 0 0 15px rgba(96, 165, 250, 0.6), 0 0 5px rgba(96, 165, 250, 0.4);">11. Documents &amp; Evidence</h2><ul style="max-width: 100%; box-sizing: border-box; padding-left: 20px; overflow: hidden;"><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Submitted &amp; approved: Preliminary and Final Safety Form (includes lab photos, facilities, PPE, training evidence, waste-management workflows).</li><li style="word-wrap: break-word; overflow-wrap: break-word; box-sizing: border-box; overflow: hidden;" style="word-wrap: break-word; overflow-wrap: break-word; padding: 0; margin: 0; box-sizing: border-box; width: 100%; display: block; overflow: hidden;">Updates: this page and the Safety Form will be continuously updated with new results and changes.</li></ul>








</div>
  </main>

  <script src="/assets/js/main.js"></script>
  <footer class="site-footer">
    <img src="/assets/images/logo6.webp" alt="页脚图片">
  </footer>
</body>
</html>
